After RH-Δcps treatment, with the increase of tumor-specific CD8+ T cells and CD4+ T cells in tumors, the IFN-γ level increased 5- to 10-fold in tumor, but there is no significant change in the whole body (Baird et al., 2013a). The gene discussed is IFNG; the disease is neoplasm.